Organization
University of Liverpool
7 clinical trials
5 abstracts
Abstract
Efficacy, cellular and molecular determinants of PD-1 checkpoint inhibition in relapsed mesothelioma.Org: University of Leicester and Leicester University Hospitals, University of Southampton, Harry Perkins Institute of Medical Research, Perth, Australia, Liverpool, United Kingdom,
Clinical trial
Dolutegravir in Pregnant HIV Mothers and Their NeonatesStatus: Completed, Estimated PCD: 2020-10-20
Abstract
Radiation dose esclation with contact X-ray brachytherapy (Papillon) and quality of life in patients with rectal cancer: Results from the phase 3 randomised trial OPERA.Org: University of Liverpool, Centre Antoine Lacassagne, Clatterbridge Cancer Centre NHS FT, Imperial College,
Clinical trial
AGILE: Seamless Phase I/IIa Platform for the Rapid Evaluation of Candidates for COVID-19 TreatmentStatus: Active (not recruiting), Estimated PCD: 2023-12-18
Clinical trial
Doravirine Dose Optimisation in PregnancyStatus: Recruiting, Estimated PCD: 2025-11-01
Clinical trial
A Pragmatic Randomized Trial to Evaluate the Comparative Effectiveness Between Dapagliflozin and Standard of Care in Type 2 Diabetes Patients (DECIDE Study)Status: Active (not recruiting), Estimated PCD: 2024-07-31
Clinical trial
Pharmacokinetics of Drugs Used to Treat Uncomplicated Malaria in Breastfeeding Mother-infant Pairs: An Observational Pharmacokinetic StudyStatus: Recruiting, Estimated PCD: 2024-12-01
Clinical trial
Pharmacokinetics of Drugs Used to Treat Drug-sensitive Tuberculosis in Breastfeeding Mother-infant Pairs: An Observational Pharmacokinetic StudyStatus: Recruiting, Estimated PCD: 2023-12-20
Clinical trial
Investigation of the Pharmacokinetics of Atazanavir in Pregnant Women, Individuals at Extremes of BMI, Children, and Adolescents: An Observational Study Nested Within the VirTUAL ConsortiumStatus: Completed, Estimated PCD: 2020-05-01
Abstract
REFINE-Lung: A multicentre phase III study to determine the optimal frequency of pembrolizumab in non-small cell lung cancer utilising a novel multi-arm design.Org: Imperial College London, MRC Clinical Trials Unit UCL, Christie Hospital NHS Foundation Trust and the University of Manchester, The Royal Marsden NHS Foundation Trust and Institute of Cancer Research, University of Liverpool,
Abstract
Gene expression comparison between primary aggressive luminal breast cancer and paired axillary and sentinel lymph node metastasis.Org: Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, China, Jiangsu Simcere Diagnostics Co., Ltd., Nanjing Simcere Medical Laboratory Science Co., Ltd., University of Liverpool,
Abstract
A NOVEL SMALL MOLECULE, MBS2133, MODULATES OSTEOCLAST PRE-CURSOR METABOLISM TO INHIBIT OSTEOCLAST DIFFERENTIATION: AN ALTERNATIVE THERAPY FOR OSTEOLYTIC PATHOLOGY IN RAOrg: Istesso Ltd, London, United Kingdom, Johnson and Johnson Innovation, London, United Kingdom, University of Glasgow, University of Liverpool, University of Aberdeen,